Research Article

Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer

Figure 10

Chemotherapy sensitivity analysis between two risk groups. (a) IC50 of gemcitabine between two risk groups. (b) IC50 of paclitaxel between two risk groups. (c) IC50 of cytarabine between two risk groups. (d) IC50 of doxorubicin between two risk groups.
(a)
(b)
(c)
(d)